Dimethyl sulfoxide therapy in subjective tinnitus of unknown origin.
In fifteen patients affected by essential nonvibratory tinnitus, local applications in the external auditive canal of 2 ml medicated DMSO spray were made. The spray solution contained DMSO integrated with anti-inflammatory and vasodilatory substances. This application was repeated every four days for a month. At the same time each patient was administered a daily intramuscular injection of a preparation that contained DMSO and a vasodilatory component. The therapeutic effect was evaluated through the subjective modification of the symptom and functional tests of the auditory system. Of the fifteen patients treated, the tinnitus symptom completely disappeared in nine, and did not return during a one-year observation period. The patient's symptoms diminished in two cases, and in four cases the permanent tinnitus became occasional, triggered principally by environmental cold. It is important to note that among the concomitant signs, the five patients with vertigo noted improvement. Hypacusis diminished in three of the six patients affected. Insomnia disappeared in eight and diminished in seven cases. The rise in the average tympanic membrane temperature from 36.8 degrees C before to 37.9 degrees C after treatment was noteworthy. This could indicate an improvement of the blood flow in the inner ear.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001299:Audiometry; D001831:Body Temperature; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D004423:Ear; D004724:Endoscopy; D006801:Humans; D008875:Middle Aged; D014012:Tinnitus / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014432:Tympanic Membrane / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D014665:Vasodilator Agents; D004121:Dimethyl Sulfoxide